Executive Leadership Team

Yehia Hashad, M.D.

Executive Vice President of Research & Development and Chief Medical Officer

Yehia Hashad is an ophthalmologist and retinal specialist with more than 25 years of leadership experience in various ophthalmology global research and development roles, including his current role as the Executive Vice President of Research & Development and Chief Medical Officer at Bausch + Lomb.

Most recently, Dr. Hashad was with Allergan/AbbVie where he served as Senior Vice President and Head of R&D for Allergan Aesthetics from 2020 through August 2021. There, he oversaw the development of more than 40 programs that spanned pharmaceutical products, fillers, reconstructive surgery, devices and consumer skin care. From 2010 until Allergan's acquisition by AbbVie in 2020, Dr. Hashad held a number of executive R&D positions at Allergan, including Senior Vice President and Head of Global Clinical Development; Vice President and Global Head of Clinical Development, Ophthalmology, Dermatology and Medical Aesthetics; and Vice President and Global Head of the Ophthalmology and Retina therapeutic areas.

Prior to Allergan, Dr. Hashad spent five years with Novartis Pharma AG, where he served as a Global Medical Director for age-related macular degeneration-related treatments Visudyne® and Lucentis® and as a Medical Director, Ophthalmology, for the European region. From 1996 to 2005, he held positions of increasing responsibility at T3A Pharma Group.

Dr. Hashad obtained his Master of Science in Medical and Surgical Ophthalmology from Cairo University and a business degree from INSEAD in France. He previously served on the boards of The Glaucoma Research Foundation and the National Alliance of Eye and Vision Research and is currently a board adviser for the University of California Irvine Research Center.